Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0

After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of...

Full description

Saved in:
Bibliographic Details
HerausgeberIn:
Sonstige:
Year of Publication:2021
Language:English
Physical Description:1 electronic resource (240 p.)
Tags: Add Tag
No Tags, Be the first to tag this record!
id 993545142804498
ctrlnum (CKB)5400000000040638
(oapen)https://directory.doabooks.org/handle/20.500.12854/68385
(EXLCZ)995400000000040638
collection bib_alma
record_format marc
spelling Ecke, Thorsten edt
Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
Basel, Switzerland MDPI - Multidisciplinary Digital Publishing Institute 2021
1 electronic resource (240 p.)
text txt rdacontent
computer c rdamedia
online resource cr rdacarrier
After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.
English
Medicine bicssc
Metallothionein
urothelium
urothelial cancer
cadmium exposure
zinc transporter
bladder
TAGLN
F-actin
PTEN
p53
tumorigenesis
proliferation
invasion
TERT promoter mutations
FGFR3
non muscle invasive bladder cancer
BCG therapy
bladder cancer
JAK-STAT pathway
combination therapy
oncolytic adenovirus
virotherapy
STAT3/5 inhibitor
JAK inhibitor
XVir-N-31
bladder cancer detection
urinary biomarkers
DNA methylation
ECRG4
ITIH5
biomarker
cancer
grade
metabolomics
MS
NMR
biomarkers
tumor markers
prognosis
heparanase
syndecan-1
heparan sulfate proteoglycans (HSPGs)
urothelial carcinoma
miRNA
quantitative PCR
tumor marker
voided urine cytology
KDM7A
histone demethylase
TC-E 5002
androgen receptor
drug resistance
non-invasive detection
telomerase
somatic mutations
TERT promoter region
muscle-invasive bladder cancer
chemotherapy
immunotherapy
personalized medicine
predictive biomarker
survivin
BIRC5
macrophage
KRT20
ERBB2
MIBC
prediction
RT-qPCR
adjuvant chemotherapy
survival
3-03943-685-6
3-03943-686-4
Otto, Thomas edt
Ecke, Thorsten oth
Otto, Thomas oth
language English
format eBook
author2 Otto, Thomas
Ecke, Thorsten
Otto, Thomas
author_facet Otto, Thomas
Ecke, Thorsten
Otto, Thomas
author2_variant t e te
t o to
author2_role HerausgeberIn
Sonstige
Sonstige
title Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
spellingShingle Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_full Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_fullStr Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_full_unstemmed Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_auth Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_new Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
title_sort diagnostic, prognostic and predictive biological markers in bladder cancer - illumination of a vision 2.0
publisher MDPI - Multidisciplinary Digital Publishing Institute
publishDate 2021
physical 1 electronic resource (240 p.)
isbn 3-03943-685-6
3-03943-686-4
illustrated Not Illustrated
work_keys_str_mv AT eckethorsten diagnosticprognosticandpredictivebiologicalmarkersinbladdercancerilluminationofavision20
AT ottothomas diagnosticprognosticandpredictivebiologicalmarkersinbladdercancerilluminationofavision20
status_str n
ids_txt_mv (CKB)5400000000040638
(oapen)https://directory.doabooks.org/handle/20.500.12854/68385
(EXLCZ)995400000000040638
carrierType_str_mv cr
is_hierarchy_title Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0
author2_original_writing_str_mv noLinkedField
noLinkedField
noLinkedField
_version_ 1796651990681387009
fullrecord <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>04486nam-a2201165z--4500</leader><controlfield tag="001">993545142804498</controlfield><controlfield tag="005">20231214133100.0</controlfield><controlfield tag="006">m o d </controlfield><controlfield tag="007">cr|mn|---annan</controlfield><controlfield tag="008">202105s2021 xx |||||o ||| 0|eng d</controlfield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(CKB)5400000000040638</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(oapen)https://directory.doabooks.org/handle/20.500.12854/68385</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(EXLCZ)995400000000040638</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Ecke, Thorsten</subfield><subfield code="4">edt</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Diagnostic, Prognostic and Predictive Biological Markers in Bladder Cancer - Illumination of a Vision 2.0</subfield></datafield><datafield tag="260" ind1=" " ind2=" "><subfield code="a">Basel, Switzerland</subfield><subfield code="b">MDPI - Multidisciplinary Digital Publishing Institute</subfield><subfield code="c">2021</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 electronic resource (240 p.)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">text</subfield><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">computer</subfield><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">online resource</subfield><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">After our successful first Special Issue about bladder cancer, we proceeded with the second issue. Again, many international scientists submitted their newest research results in that extremely interesting field and followed our call for submissions. It is not only the collection and combination of old and new markers that could develop new possibilities, but also the focus on different classifications and sub-classifications that will unveil new ways in diagnostic and therapeutic approaches. It seems that the two established diagnostic tools will still play an important role, but new markers and diagnostics tools will present more detailed and more differentiated possibilities in the treatment of urinary bladder cancer. This second Special Issue is full of scientific results that could provide new ways to help patients with instruments for early diagnostics and with predictive and prognostic markers on their way to finding new and personalized strategies for therapy. The editors thank all of the submitting authors for their efforts and time spent on each manuscript. We hope that this Special Issue will prove useful to research work in bladder cancer in the future. We hope that many talented researchers will use multiple forms of art to improve their professional successes and to ameliorate diagnostics and therapy in bladder cancer.</subfield></datafield><datafield tag="546" ind1=" " ind2=" "><subfield code="a">English</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Medicine</subfield><subfield code="2">bicssc</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">Metallothionein</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelium</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelial cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cadmium exposure</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">zinc transporter</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TAGLN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">F-actin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">PTEN</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">p53</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumorigenesis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">proliferation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">invasion</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TERT promoter mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">FGFR3</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non muscle invasive bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BCG therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK-STAT pathway</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">combination therapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">oncolytic adenovirus</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">virotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">STAT3/5 inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">JAK inhibitor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">XVir-N-31</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">bladder cancer detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urinary biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">DNA methylation</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ECRG4</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ITIH5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">grade</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">metabolomics</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MS</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">NMR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">biomarkers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor markers</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prognosis</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparanase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">syndecan-1</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">heparan sulfate proteoglycans (HSPGs)</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">urothelial carcinoma</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">miRNA</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">quantitative PCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">tumor marker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">voided urine cytology</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KDM7A</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">histone demethylase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TC-E 5002</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">androgen receptor</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">drug resistance</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">non-invasive detection</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">telomerase</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">somatic mutations</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">TERT promoter region</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">muscle-invasive bladder cancer</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">immunotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">personalized medicine</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">predictive biomarker</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survivin</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">BIRC5</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">macrophage</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">KRT20</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">ERBB2</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">MIBC</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">prediction</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">RT-qPCR</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">adjuvant chemotherapy</subfield></datafield><datafield tag="653" ind1=" " ind2=" "><subfield code="a">survival</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-685-6</subfield></datafield><datafield tag="776" ind1=" " ind2=" "><subfield code="z">3-03943-686-4</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otto, Thomas</subfield><subfield code="4">edt</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Ecke, Thorsten</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Otto, Thomas</subfield><subfield code="4">oth</subfield></datafield><datafield tag="906" ind1=" " ind2=" "><subfield code="a">BOOK</subfield></datafield><datafield tag="ADM" ind1=" " ind2=" "><subfield code="b">2023-12-15 05:42:22 Europe/Vienna</subfield><subfield code="f">system</subfield><subfield code="c">marc21</subfield><subfield code="a">2022-04-04 09:22:53 Europe/Vienna</subfield><subfield code="g">false</subfield></datafield><datafield tag="AVE" ind1=" " ind2=" "><subfield code="i">DOAB Directory of Open Access Books</subfield><subfield code="P">DOAB Directory of Open Access Books</subfield><subfield code="x">https://eu02.alma.exlibrisgroup.com/view/uresolver/43ACC_OEAW/openurl?u.ignore_date_coverage=true&amp;portfolio_pid=5337915360004498&amp;Force_direct=true</subfield><subfield code="Z">5337915360004498</subfield><subfield code="b">Available</subfield><subfield code="8">5337915360004498</subfield></datafield></record></collection>